{
  "actions": [
    {
      "acted_at": "2020-03-04",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2020-03-04",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3385-116",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "K000367",
      "district": null,
      "name": "Klobuchar, Amy",
      "original_cosponsor": true,
      "sponsored_at": "2020-03-04",
      "state": "MN",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-03-04",
  "number": "3385",
  "official_title": "A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "BENEFIT Act of 2020",
  "sponsor": {
    "bioguide_id": "W000437",
    "district": null,
    "name": "Wicker, Roger F.",
    "state": "MS",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-03-04",
  "subjects": [
    "Drug safety, medical device, and laboratory regulation",
    "Health",
    "Health information and medical records",
    "Product development and innovation"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2020-03-04",
    "date": "2021-05-14T18:42:08Z",
    "text": "Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2020 or the BENEFIT Act of 2020\n\nThis bill requires the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs.\n\nAfter a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "BENEFIT Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "BENEFIT Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.",
      "type": "official"
    }
  ],
  "updated_at": "2022-02-09T03:11:47Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s3385.xml"
}